DIGITALX LIMITED — Director's Dealing 2021

Mar 21, 2021

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	DigitalX Limited
ABN	59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Toby Albert Hicks
Date of last notice	4 December 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Emboodhu Pty Ltd as trustee for the TA and EL Hicks Family Trust of which Mr Hicks is a Director and beneficiary of the trust.
Date of change	22 March 2021
No. of securities held prior to change	Indirect 694,444 Fully Paid Ordinary Shares1. 7,500,000 Performance Rights. Subject to the Company Shares trading on ASX achieving a volume weighted average trading price of not less than $0.09 for not less than 15 consecutive trading days within three years from the date of issue, the Performance Rights will automatically be capable of conversion into Shares within 6 months1. 2,500,000 Unlisted Options exercisable at $0.10 each on or before 30 June 20241. 1. Securities held by Emboodhu Pty Ltd as trustee for the TA and EL Hicks Family Trust of which Mr Hicks is a Director and beneficiary of the trust.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	Fully Paid Ordinary Shares Performance Rights
Number acquired	7,500,000 Fully Paid Ordinary Shares
Number disposed	7,500,000 Performance Rights
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil
No. of securities held after change	Indirect 8,194,444 Fully Paid Ordinary Shares1 2,500,000 Unlisted Options exercisable at $0.10 each on or before 30 June 20241. 1. Securities held by Emboodhu Pty Ltd as trustee for the TA and EL Hicks Family Trust of which Mr Hicks is a Director and beneficiary of the trust.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Conversion of 7,500,000 Performance Rights as a result of meeting vesting conditions as detailed in the Company’s Notice of Meeting dated 21 November 2019.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

==> picture [434 x 279] intentionally omitted <==

----- Start of picture text -----

Detail of contract N/A
Nature of interest
Name of registered holder
(if issued securities)
Date of change
No. and class of securities to which
interest related prior to change
Note: Details are only required for a contract in
relation to which the interest has changed
Interest acquired
Interest disposed
Value/Consideration
Note: If consideration is non-cash, provide details
and an estimated valuation
----- End of picture text -----

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	DigitalX Limited
ABN	59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

Name of Director	Leigh Daniel Travers
Date of last notice	4 December 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Direct
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	N/A
Date of change	22 March 2021
No. of securities held prior to change	Direct 641,026 Fully Paid Ordinary Shares. 9,000,000 Performance Rights, subject to performance-based vesting conditions, and expiring 10 December 2023. 9,000,000 Performance Rights, subject to performance-based vesting conditions, and expiring on or before 12 December 2022. Indirect 5,000,000 Fully Paid Ordinary Shares.1 1. Held by Leethal Pty Ltd, an entity associated with Mr Travers.

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

Class	Fully Paid Ordinary Shares. Performance Rights, subject to performance-based vesting conditions, and expiring on or before 12 December 2022.
Number acquired	9,000,000 Fully Paid Ordinary Shares
Number disposed	9,000,000 Performance Rights
Value/Consideration Note: If consideration is non-cash, provide details and estimated valuation	Nil
No. of securities held after change	Direct 9,641,026 Fully Paid Ordinary Shares. 9,000,000 Performance Rights, subject to performance-based vesting conditions, and expiring 10 December 2023. Indirect 5,000,000 Fully Paid Ordinary Shares.1 1. Held by Leethal Pty Ltd, an entity associated with Mr Travers.
Nature of change Example: on-market trade, off-market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy-back	Conversion of 9,000,000 Performance Rights as a result of meeting vesting conditions, as detailed in the Company’s Notice of Meeting dated 21 November 2019.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change. Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired
Interest disposed

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

Value/Consideration Note: If consideration is non-cash, provide details and an estimated valuation Interest after change

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Rule 3.19A.2

Appendix 3Y

Change of Director’s Interest Notice

Information or documents not available now must be given to ASX as soon as available. Information and documents given to ASX become ASX’s property and may be made public.

Introduced 30/09/01 Amended 01/01/11

Name of entity	DigitalX Limited
ABN	59 009 575 035

We (the entity) give ASX the following information under listing rule 3.19A.2 and as agent for the director for the purposes of section 205G of the Corporations Act.

We (the entity) give ASX the following the director for the purposes of section	information under listing rule 3.19A.2 and as agent for 205G of the Corporations Act.
Name of Director	Peter Irwin Rubinstein
Date of last notice	4 December 2020

Part 1 - Change of director’s relevant interests in securities

In the case of a trust, this includes interests in the trust made available by the responsible entity of the trust

Note: In the case of a company, interests which come within paragraph (i) of the definition of “notifiable interest of a director” should be disclosed in this part.

Direct or indirect interest	Indirect
Nature of indirect interest (including registered holder) Note: Provide details of the circumstances giving rise to the relevant interest.	Irwin Biotech Nominees Pty Ltd ATF BIOA Trust. Peter Irwin Rubinstein is the sole director and shareholder of Irwin Biotech Nominees Pty Ltd and sole member of PIR Super Fund BIOA Trust
Date of change	22 March 2021

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 1

Appendix 3Y Change of Director’s Interest Notice

No. of securities held prior to change	Direct 617,284 Fully Paid Ordinary Shares Indirect 13,196,296 Fully Paid Ordinary Shares1 5,470,000 Fully Paid Ordinary Shares2 3,694,444 Fully Paid Ordinary Shares3 7,200,000 Fully Paid Ordinary Shares4 1,000,000 Unlisted Options exercisable at $0.22 each on or before 10 December 20231 1,500,000 Unlisted Options exercisable at $0.25 each on or before 10 December 20231 2,000,000 Unlisted Options exercisable at $0.30 each on or before the date 10 December 20231 3,000,000 Performance Rights, subject to performance-based vesting conditions, and expiring on or before 12 December 20222 1. Held by Irwin Biotech Nominees Pty Ltd. 2. Held by Irwin Biotech Nominees Pty Ltd ATF BIOA Trust 3. Held by RIP Opportunities Pty Ltd ATF PIR Super Fund 4. Held by ValueAdmin.Com Pty Ltd.
Class	Fully Paid Ordinary Shares Performance Rights, subject to performance-based vesting conditions, and expiring on or before 12 December 2022
Number acquired	3,000,000 Fully Paid Ordinary Shares
Number disposed	3,000,000 Performance Rights, subject to performance-based vesting conditions, and expiring on or before 12 December 2022
Value/Consideration Note: If consideration is non‐cash, provide details and estimated valuation	Nil

• See chapter 19 for defined terms.

Appendix 3Y Page 2

01/01/2011

Appendix 3Y Change of Director’s Interest Notice

No. of securities held after change

Direct 617,284 Fully Paid Ordinary Shares Indirect 13,196,296 Fully Paid Ordinary Shares1 8,470,000 Fully Paid Ordinary Shares2 3,694,444 Fully Paid Ordinary Shares3 7,200,000 Fully Paid Ordinary Shares4 1,000,000 Unlisted Options exercisable at $0.22 each on or before 10 December 20231 1,500,000 Unlisted Options exercisable at $0.25 each on or before 10 December 20231 2,000,000 Unlisted Options exercisable at $0.30 each on or before the date 10 December 20231 1. Held by Irwin Biotech Nominees Pty Ltd. 2. Held by Irwin Biotech Nominees Pty Ltd ATF BIOA Trust 3. Held by RIP Opportunities Pty Ltd ATF PIR Super Fund 4. Held by ValueAdmin.Com Pty Ltd

Nature of change Example: on‐market trade, off‐market trade, exercise of options, issue of securities under dividend reinvestment plan, participation in buy‐back

Conversion of 3,000,000 Performance Rights as a result of meeting vesting conditions, as detailed in the Company’s Notice of Meeting dated 21 November 2019.

Part 2 – Change of director’s interests in contracts

Note: In the case of a company, interests which come within paragraph (ii) of the definition of “notifiable interest of a director” should be disclosed in this part.

Detail of contract	N/A
Nature of interest
Name of registered holder (if issued securities)
Date of change
No. and class of securities to which interest related prior to change Note: Details are only required for a contract in relation to which the interest has changed
Interest acquired

• See chapter 19 for defined terms.

01/01/2011 Appendix 3Y Page 3

Appendix 3Y Change of Director’s Interest Notice

Interest disposed Value/Consideration Note: If consideration is non‐cash, provide details and an estimated valuation

Part 3 –[+] Closed period

Part 3 –+Closed period
Were the interests in the securities or contracts detailed above traded during a+closed period where prior written clearance was required?	No
If so, was prior written clearance provided to allow the trade to proceed during this period?
If prior written clearance was provided, on what date was this provided?

• See chapter 19 for defined terms.

Appendix 3Y Page 4

01/01/2011